The definition of functional gastrointestinal disorders (FGID) used to be disorders that do not manifest into organic abnormalities. However, it was pointed out that chronic GI dysfunctions can develop following bacterial infections such as acute gastroenteritis and viral infections, and some organic changes in the epithelial cell struc- This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
| INTRODUCTION
Functional gastrointestinal disorders (FGID) was used to be considered as disorders that do not have organic or biochemical etiology, as abnormalities were not observed endoscopically or in the blood test results. Recently, advancements have been made in the gross examination as well as the microscopic examination of the GI tract, and the findings of patients with FGID that are different from those of healthy people, including pathological changes, immune response, and other findings, began to come to light. In addition, it has been shown that infectious diseases are often the cause of FGID, and this has gathered much attention. Attempts have also been made to learn about organic abnormalities in order to understand the clinical manifestations of FGID. FGID is classified into functional dyspepsia (FD) and irritable bowel syndrome (IBS), whose symptoms are mainly associated with the upper GI tract and the lower GI tract, respectively. In this report, correlations between infectious diseases, intestinal bacteria, and immune response and FD and IBS are summarized. symptoms only, 21%). The concept of PI-IBS was introduced earlier than PI-FD, but the actual number of patients with PI-FD is likely to be higher. Studies on PI-FD also focused attention on the duodenal mucosa, and its biopsy specimens have been pathologically analyzed.
| Infectious diseases and FGID

| Helicobacter pylori infection and FD
As a result, a high number of aggregated CD8+ T cells and CD68+ macrophages were observed in PI-FD patients, but the number of CD4+ T cells was low. 6 PI-IBS has been associated with an increased number of neuroendocrine cells in the epithelial cells and IELs, but this was not the case with PI-FD. This means that GI infections possibly manifest differently in the upper and lower GI tract. It would be useful to examine organ-specific postinflammation changes in the future PI-FD studies.
| Postinfectious IBS (PI-IBS)
Postinfectious development of IBS, whose symptoms are mostly associated with the lower GI tract, has been known for quite some time.
The first report was made during WWII when a British soldier who was infected with amebic dysentery in North Africa developed IBS symptoms after returning home. This case is considered the beginning of the PI-IBS concept. A prospective study of patients who were involved in a group GI infection showed that 31% of patients had IBS symptoms, and the symptoms were still present a year after the infection. Another study reported that 25% of acute enteritis patients had IBS symptoms 6 months after getting injected.
Subsequently, a large-scale prospective study was performed in the UK in 584 308 healthy people. A total of 318 people developed bacterial enteritis during the observational period, and 12 of whom were diagnosed with IBS a year after the onset of bacterial enteritis.
The risk of developing IBS was 4%/y, whereas in people who did not develop bacterial enteritis, the risk was 0.35%/y. It was thus demonstrated that acute enteritis is associated with a significantly higher risk (Figure 1 ). In summary, histological and immunological evaluation has so far helped us to understand that acute infectious diseases trigger mild mucosal changes in the lower GI tract and is closely related to IBS symptoms.
| Intestinal bacteria and FGID
Correlations between intestinal bacteria and FGID have been pointed out, as the intestinal microbiota of patients with FGID is different from that of healthy people and symptoms often improve with an antiflatulent or an antibiotic agent. The number of intestinal bacteria is low in the stomach and jejunum (10 1 -10 3 cfu/mL), but it increases in the ilium (10 4 -10 7 cfu/mL) and the colon (10 10 -10 13 cfu/mL). In terms of bacterial species, more aerobic bacteria are observed on the jejunum side and more anaerobic bacteria on the ilium side. As thus, the intraluminal environment differs greatly depending on the part of the intestinal tract. 
